• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓细胞 Kdm6b 缺失导致严重的动脉粥样硬化。

Myeloid Kdm6b deficiency results in advanced atherosclerosis.

机构信息

Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.

Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands; Department of Pathology and Department of Molecular Genetics, CARIM, Maastricht University, Universiteitssingel 50, 6229 ER, Maastricht, The Netherlands.

出版信息

Atherosclerosis. 2018 Aug;275:156-165. doi: 10.1016/j.atherosclerosis.2018.05.052. Epub 2018 Jun 1.

DOI:10.1016/j.atherosclerosis.2018.05.052
PMID:29908485
Abstract

BACKGROUND AND AIMS

Atherosclerosis is a lipid-driven chronic inflammatory disorder of the arteries, and monocytes and macrophages play a central role in this process. Within the atherosclerotic lesion, macrophages can scavenge modified lipids and become the so-called foam cells. We previously reported that the epigenetic enzyme Kdm6b (also known as Jmjd3) controls the pro-fibrotic transcriptional profile of peritoneal foam cells. Given the importance of these cells in atherosclerosis, we now studied the effect of myeloid Kdm6b on disease progression.

METHODS

Bone marrow of myeloid Kdm6b deficient (Kdm6b) mice or wild type littermates (Kdm6b) was transplanted to lethally irradiated Ldlr mice fed a high fat diet for 9 weeks to induce atherosclerosis.

RESULTS

Lesion size was similar in Kdm6b and Kdm6b transplanted mice. However, lesions of Kdm6b mice contained more collagen and were more necrotic. Pathway analysis on peritoneal foam cells showed that the pathway involved in leukocyte chemotaxis was most significantly upregulated. Although macrophage and neutrophil content was similar after 9 weeks of high fat diet feeding, the relative increase in collagen content and necrosis revealed that atherosclerotic lesions in Kdm6b mice progress faster.

CONCLUSION

Myeloid Kdm6b deficiency results in more advanced atherosclerosis.

摘要

背景和目的

动脉粥样硬化是一种由脂质驱动的动脉慢性炎症性疾病,单核细胞和巨噬细胞在这个过程中起核心作用。在动脉粥样硬化病变中,巨噬细胞可以吞噬修饰后的脂质,成为所谓的泡沫细胞。我们之前报道过,表观遗传酶 Kdm6b(也称为 Jmjd3)控制着腹膜泡沫细胞的促纤维化转录特征。鉴于这些细胞在动脉粥样硬化中的重要性,我们现在研究了髓样细胞 Kdm6b 对疾病进展的影响。

方法

将骨髓来源的 Kdm6b 缺陷型(Kdm6b)小鼠或野生型同窝仔鼠(Kdm6b)的骨髓移植到接受高脂肪饮食喂养 9 周以诱导动脉粥样硬化的致死性辐射 Ldlr 小鼠中。

结果

Kdm6b 和 Kdm6b 移植小鼠的病变大小相似。然而,Kdm6b 小鼠的病变含有更多的胶原,并且更坏死。对腹膜泡沫细胞的通路分析表明,白细胞趋化通路被显著上调。尽管在高脂肪饮食喂养 9 周后,巨噬细胞和中性粒细胞含量相似,但胶原含量和坏死的相对增加表明 Kdm6b 小鼠的动脉粥样硬化病变进展更快。

结论

髓样细胞 Kdm6b 缺乏导致更严重的动脉粥样硬化。

相似文献

1
Myeloid Kdm6b deficiency results in advanced atherosclerosis.骨髓细胞 Kdm6b 缺失导致严重的动脉粥样硬化。
Atherosclerosis. 2018 Aug;275:156-165. doi: 10.1016/j.atherosclerosis.2018.05.052. Epub 2018 Jun 1.
2
Hematopoietic arginase 1 deficiency results in decreased leukocytosis and increased foam cell formation but does not affect atherosclerosis.造血精氨酸酶1缺乏导致白细胞增多减少和泡沫细胞形成增加,但不影响动脉粥样硬化。
Atherosclerosis. 2017 Jan;256:35-46. doi: 10.1016/j.atherosclerosis.2016.11.018. Epub 2016 Nov 16.
3
Serum Amyloid A Facilitates Early Lesion Development in Ldlr-/- Mice.血清淀粉样蛋白A促进Ldlr-/-小鼠早期病变发展。
J Am Heart Assoc. 2015 Jul 17;4(7):e001858. doi: 10.1161/JAHA.115.001858.
4
CalDAG-GEFI Deficiency Reduces Atherosclerotic Lesion Development in Mice.钙依赖性鸟苷酸交换因子I(CalDAG-GEFI)缺乏可减少小鼠动脉粥样硬化病变的发展。
Arterioscler Thromb Vasc Biol. 2016 May;36(5):792-9. doi: 10.1161/ATVBAHA.115.306347. Epub 2016 Mar 17.
5
Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.骨髓细胞胰岛素降解酶缺乏症增加 LDL 受体缺陷型小鼠的动脉粥样硬化。
Cardiovasc Pathol. 2013 Nov-Dec;22(6):458-64. doi: 10.1016/j.carpath.2013.03.006. Epub 2013 May 17.
6
Progranulin in the hematopoietic compartment protects mice from atherosclerosis.粒细胞集落刺激因子在造血组织中保护小鼠免受动脉粥样硬化的影响。
Atherosclerosis. 2018 Oct;277:145-154. doi: 10.1016/j.atherosclerosis.2018.08.042. Epub 2018 Aug 30.
7
Leukocyte cathepsin C deficiency attenuates atherosclerotic lesion progression by selective tuning of innate and adaptive immune responses.白细胞组织蛋白酶C缺乏通过选择性调节先天性和适应性免疫反应来减轻动脉粥样硬化病变进展。
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):79-86. doi: 10.1161/ATVBAHA.114.304292. Epub 2014 Nov 13.
8
Glutaredoxin 2a overexpression in macrophages promotes mitochondrial dysfunction but has little or no effect on atherogenesis in LDL-receptor null mice.巨噬细胞中谷氧还蛋白2a的过表达会促进线粒体功能障碍,但对低密度脂蛋白受体缺失小鼠的动脉粥样硬化几乎没有影响。
Atherosclerosis. 2015 Jul;241(1):69-78. doi: 10.1016/j.atherosclerosis.2015.04.805. Epub 2015 Apr 26.
9
Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.骨髓细胞中 Dab2(Disabled Homolog 2)缺失加剧 LDLR(低密度脂蛋白受体)缺失小鼠肝内炎症和动脉粥样硬化斑块形成-简报
Arterioscler Thromb Vasc Biol. 2018 May;38(5):1020-1029. doi: 10.1161/ATVBAHA.117.310467. Epub 2018 Mar 29.
10
Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages.髓样 HMG-CoA(3-羟-3-甲基戊二酰辅酶 A)还原酶通过调节巨噬细胞迁移来决定动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2590-2600. doi: 10.1161/ATVBAHA.118.311664.

引用本文的文献

1
Comparative analysis of blood whole transcriptome profiles in Yili horses pre- and post-5000-meter racing.伊犁马5000米赛跑前后血液全转录组图谱的比较分析
Front Genet. 2025 Aug 29;16:1651628. doi: 10.3389/fgene.2025.1651628. eCollection 2025.
2
Roles and mechanisms of histone methylation in vascular aging and related diseases.组蛋白甲基化在血管衰老及相关疾病中的作用和机制
Clin Epigenetics. 2025 Feb 23;17(1):35. doi: 10.1186/s13148-025-01842-y.
3
Emerging role of Jumonji domain-containing protein D3 in inflammatory diseases.
含Jumonji结构域蛋白D3在炎症性疾病中的新作用。
J Pharm Anal. 2024 Sep;14(9):100978. doi: 10.1016/j.jpha.2024.100978. Epub 2024 Apr 16.
4
Knowledge mapping of digital medicine in cardiovascular diseases from 2004 to 2022: A bibliometric analysis.2004年至2022年心血管疾病数字医学的知识图谱:一项文献计量分析。
Heliyon. 2024 Feb 1;10(3):e25318. doi: 10.1016/j.heliyon.2024.e25318. eCollection 2024 Feb 15.
5
Epigenetic regulation of innate immune dynamics during inflammation.炎症过程中固有免疫动力学的表观遗传调控。
J Leukoc Biol. 2024 Mar 29;115(4):589-606. doi: 10.1093/jleuko/qiae026.
6
Ezh2 emerges as an epigenetic checkpoint regulator during monocyte differentiation limiting cardiac dysfunction post-MI.Ezh2 在单核细胞分化过程中作为一种表观遗传检查点调节剂出现,限制了 MI 后心脏功能障碍。
Nat Commun. 2023 Jul 25;14(1):4461. doi: 10.1038/s41467-023-40186-0.
7
Targeting epigenetic modifiers to reprogramme macrophages in non-resolving inflammation-driven atherosclerosis.靶向表观遗传修饰因子以重编程非消退性炎症驱动的动脉粥样硬化中的巨噬细胞。
Eur Heart J Open. 2021 Aug 17;1(2):oeab022. doi: 10.1093/ehjopen/oeab022. eCollection 2021 Sep.
8
Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.抑制组蛋白 3 赖氨酸 27 去甲基酶的治疗潜力:文献综述。
Clin Epigenetics. 2022 Aug 1;14(1):98. doi: 10.1186/s13148-022-01305-8.
9
A Bibliometric and Knowledge-Map Analysis of Macrophage Polarization in Atherosclerosis From 2001 to 2021.2001 年至 2021 年动脉粥样硬化中巨噬细胞极化的文献计量学和知识图谱分析
Front Immunol. 2022 Jun 20;13:910444. doi: 10.3389/fimmu.2022.910444. eCollection 2022.
10
Diverse Epigenetic Regulations of Macrophages in Atherosclerosis.动脉粥样硬化中巨噬细胞的多种表观遗传调控
Front Cardiovasc Med. 2022 Mar 29;9:868788. doi: 10.3389/fcvm.2022.868788. eCollection 2022.